In neuroinflammatory diseases, systemic (blood-borne) leukocytes invade the central nervous system (CNS) and lead to tissue damage. A causal relationship between neuroinflammatory diseases and ...

Kyverna Therapeutics' miv-cel showed improved mobility and a favorable safety profile at one year in patients with stiff ...

Global Autoimmune Treatment Market was valued at USD 176.6 Billion in 2025 and is projected to expand at a 6.9% CAGR from 2026 to 2034, reaching USD 321.95 Billion by 2034, according to a new analysis ...

The company said it would share the study’s interim data with health authorities with the aim of bringing the treatment to ...

Researchers are studying the curious connection between autoimmune diseases and conditions like POTS and long COVID—in the hopes it might lead to more targeted treatments.

Our understanding of how cells interact with each other has been driven for decades by the central concept of ...

Amgen’s dazodalibep led to statistically significant and clinically meaningful results, according to preliminary Phase 3 ...

While the exact cause of Sjögren’s disease is unknown, it is believed that genetic and environmental factors may trigger the ...

Type 1 diabetes (T1D) is linked to an altered gut microbiota characterized by reduced short-chain fatty acid (SCFA) production. Oral delivery of a SCFA-yielding biotherapy in adults with T1D was ...

There are more than 100 autoimmune diseases. Here’s how they’re diagnosed.

By Christy Santhosh Sept 22 (Reuters) - Amgen said on Tuesday its experimental drug to treat an autoimmune disease that ...

Lakefront Biotherapeutics (LKFT) has a "meaningful opportunity" with its asset gamgertamig for the treatment of rare autoimmune diseases, RBC Capital Markets said in a note Wednesday. Gamgertamig has ...